Taipei, Taiwan

Ming-Hon Chuang

This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ming-Hon Chuang

Introduction

Ming-Hon Chuang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly through his work on recombinant enzymes. His innovative approach has led to advancements that benefit various applications in the industry.

Latest Patents

Ming-Hon Chuang holds a patent for "Recombinant xylanase, the preparation and use of thereof." This invention provides a genetically recombinant xylanase with high yield and good activity. The patent outlines a process for the production of this recombinant xylanase, including the coding sequence, vectors bearing the coding sequence, and transformants containing the vectors. Additionally, the invention features a column wherein the recombinant xylanase is immobilized. He has 1 patent to his name.

Career Highlights

Chuang is currently associated with the Development Center for Biotechnology, where he continues to push the boundaries of research and innovation. His work has been instrumental in enhancing the efficiency of biotechnological processes.

Collaborations

Ming-Hon Chuang has collaborated with esteemed colleagues such as Shaw-Yun Wu and King-Song Jeng. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Ming-Hon Chuang's contributions to biotechnology through his innovative patents and collaborative efforts highlight his role as a key figure in the field. His work continues to inspire advancements that have a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…